Valley National Advisers Inc. Has $2 Million Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Valley National Advisers Inc. grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 273.2% during the 1st quarter, Holdings Channel.com reports. The firm owned 21,072 shares of the exchange traded fund’s stock after buying an additional 15,426 shares during the quarter. Valley National Advisers Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,999,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in XBI. Envestnet Asset Management Inc. grew its position in SPDR S&P Biotech ETF by 5.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 126,001 shares of the exchange traded fund’s stock worth $9,201,000 after purchasing an additional 6,884 shares in the last quarter. Synovus Financial Corp lifted its stake in SPDR S&P Biotech ETF by 9.3% in the 3rd quarter. Synovus Financial Corp now owns 5,018 shares of the exchange traded fund’s stock worth $366,000 after purchasing an additional 429 shares in the last quarter. Alerus Financial NA lifted its stake in SPDR S&P Biotech ETF by 0.6% in the 3rd quarter. Alerus Financial NA now owns 54,655 shares of the exchange traded fund’s stock worth $3,991,000 after purchasing an additional 349 shares in the last quarter. Sectoral Asset Management Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 36.8% in the 3rd quarter. Sectoral Asset Management Inc. now owns 24,675 shares of the exchange traded fund’s stock worth $1,802,000 after buying an additional 6,643 shares during the last quarter. Finally, Scotia Capital Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 4.9% in the 3rd quarter. Scotia Capital Inc. now owns 41,137 shares of the exchange traded fund’s stock worth $3,004,000 after buying an additional 1,933 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 0.5 %

Shares of NYSEARCA:XBI traded down $0.49 during trading on Wednesday, reaching $90.87. The company had a trading volume of 4,676,037 shares, compared to its average volume of 10,621,511. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The company has a fifty day moving average of $90.41 and a two-hundred day moving average of $90.94. The stock has a market capitalization of $6.93 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.